PerkinElmer to acquire antibodies and reagents manufacturer BioLegend
PerkinElmer has signed a cash and stock deal worth around $5.25 billion to acquire BioLegend, a California-based antibodies and reagents manufacturer. BioLegend caters to academic ... Read More
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford Immunotec for $591 million, translating to $22 ... Read More
PerkinElmer acquisition of Horizon Discovery Group: A strategic move to enhance genomic and cell engineering capabilities
PerkinElmer, a leading US-based provider of life sciences and diagnostics solutions, has announced its acquisition of Horizon Discovery Group, a UK-based company specializing in cell ... Read More